Trial Profile
To Explore the Treatment Effect of Various Commercially Available Statins [HMG-CoA-reductase inhibitor] on Patients With Hyperlipidemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Dec 2010
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Fluvastatin (Primary) ; Lovastatin (Primary) ; Pravastatin (Primary) ; Rosuvastatin (Primary) ; Simvastatin (Primary)
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 08 Jan 2010 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov record.
- 08 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 28 Aug 2008 New trial record.